Perspectives in Molecular Imaging Using Staging Biomarkers and Immunotherapies in Alzheimer’s Disease
Sporadic Alzheimer’s disease (AD) is an emerging chronic illness characterized by a progressive pleiotropic pathophysiological mode of actions triggered during the senescence process and affecting the elderly worldwide. The complex molecular mechanisms of AD not only are supported by cholinergic, be...
Saved in:
Main Authors: | Benoît Leclerc, Abedelnasser Abulrob |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2013/589308 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insight into the Molecular Imaging of Alzheimer’s Disease
by: Abishek Arora, et al.
Published: (2016-01-01) -
Untargeted urine metabolomics reveals dynamic metabolic differences and key biomarkers across different stages of Alzheimer’s disease
by: Xiaoya Feng, et al.
Published: (2025-01-01) -
PROTEOMIC PROFILING OF BLOOD-BASED BIOMARKERS IN THE EARLY DETECTION OF ALZHEIMERS DISEASE
by: Syeda Uroosa Hashmi, et al.
Published: (2024-06-01) -
The effect of mild-stage Alzheimer’s disease on the acoustic parameters of voice
by: Emel Arslan-Sarımehmetoğlu, et al.
Published: (2025-02-01) -
Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy
by: Emma Ortiz-Islas, et al.
Published: (2025-01-01)